echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Feed Industry News > Under the policy orientation of all parties, the future API will gradually be standardized

    Under the policy orientation of all parties, the future API will gradually be standardized

    • Last Update: 2020-06-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    with the establishment of the national drug safety system, apinewe and other market demand has undergone subtle changesIn this context, the industry expects more in-depth medical reform, more policy, access threshold to upgrade and integration more big steps forwarddqr
    In the global API market, in addition to the patentapion to form a certain monopoly of the supply and demand structure, chemical API market is a completely competitive marketAt the same time, with the development of the global pharmaceutical industry, the increase of the proportion of generic drug consumption and the transfer of the production pattern of API, international manufacturers of preparations are increasingly adopting the outsourcing of API production, that is, from developing countries API manufacturers and preparation manufacturers to purchase the production of raw materials requireddqr
    Under the influence of the above trends in the global API market, an increasing number of manufacturers of API and formulation sedatives are participating in the international API supply and demand system in emerging markets, represented by China, India, Brazil and RussiaIn the specific single-species market segment of generic API, due to the raw material resources, economies of scale, technological advantages and other factors, it may still lead to a certain degree of monopoly competition or oligopolistic competitiondqr
    It is understood that the 2012 market downturn is mainly reflected in the bulk, trading antibiotic intermediates, as well as vitamins, some amino acids, anti-heat analgesics and other raw materials on the drug speciesThe reason is that these categories of products have long been in a state of overcapacity and oversupplyHowever, we have found that on one side of the industry is facing capacity saturation, on the other side there are new expansion projects, and even capacity transfer is also the phenomenon of side-by-side expansiondqr
    A common feature of capacity expansion at this stage is to expand on a larger scale to reflect the advantages of concentrationThe increase in production can be mostly a step up from the original grade, which undoubtedly exacerbates the deterioration of the industry environment: products are generally in the low-cost cycle, or even more durable;dqrwith the establishment of the national drug safety system, the market demand for API and other materials has changed slightlyIn this context, the industry expects more in-depth medical reform, more policy, access threshold to upgrade and integration more big steps forwarddqr
    In the global API market, in addition to the patentapion to form a certain monopoly of the supply and demand structure, chemical API market is a completely competitive marketAt the same time, with the development of the global pharmaceutical industry, the increase of the proportion of generic drug consumption and the transfer of the production pattern of API, international manufacturers of preparations are increasingly adopting the outsourcing of API production, that is, from developing countries API manufacturers and preparation manufacturers to purchase the production of raw materials requireddqr
    Under the influence of the above trends in the global API market, an increasing number of manufacturers of API and formulation sedatives are participating in the international API supply and demand system in emerging markets, represented by China, India, Brazil and RussiaIn the specific single-species market segment of generic API, due to the raw material resources, economies of scale, technological advantages and other factors, it may still lead to a certain degree of monopoly competition or oligopolistic competitiondqr
    It is understood that the 2012 market downturn is mainly reflected in the bulk, trading antibiotic intermediates, as well as vitamins, some amino acids, anti-heat analgesics and other raw materials on the drug species The reason is that these categories of products have long been in a state of overcapacity and oversupply However, we have found that on one side of the industry is facing capacity saturation, on the other side there are new expansion projects, and even capacity transfer is also the phenomenon of side-by-side expansion dqr
      A common feature of capacity expansion at this stage is to expand on a larger scale to reflect the advantages of concentration The increase in production can be mostly a step up from the original grade, which undoubtedly exacerbates the deterioration of the industry environment: products are generally in the low-cost cycle, or even more durable; dqr
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.